Moreover, several studies have shown that humans with Down syndrome, who harbor three copies of the APP gene that leads to the overexpression of APP protein, have an age-dependent increased risk for developing AD and develop clinical features and neuropathological changes similar to those observed in AD (for review, see [17]). This evidence concerns the gene APP and Down syndrome.